Carbon-Based Nanomaterials for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 419
Special Issue Editors
Interests: nanochemistry; nanomedicine; (carbon) nanomaterials; cancer therapy; nanodrug delivery; nanocharacterization
Special Issue Information
Dear Colleagues,
Pharmaceutics journal is pleased to announce a Special Issue on “Carbon-Based Nanomaterials for Pharmaceutical Applications”. Carbon-based nanomaterials (CBNs) have emerged as a promising platform for pharmaceutical application and are being praised not only for their tunable yet unique physicochemical properties such as size, large surface area, versatility, and adaptability, but also for their biocompatibility and safety. This nanomaterial family comprises fullerenes, carbon nanotubes (CNTs), graphene and its derivatives, carbon nanodots (CDs), carbon nanodiamonds (CNDs), and carbon nanohorns (CNHs) and has significantly reshaped the existing possibilities of drug delivery, diagnostics, theranostics, etc.
We cordially invite the high-quality, advanced original research articles and critical reviews that explore the recent advances, current challenges, and emerging opportunities within design, synthesis, and application of CBNs in pharmaceutical research and development.
Among the featured topics are design of enhanced CBN-based drug delivery (stimuli-responsive/controlled drug release/targeted therapy) systems and platforms for combined diagnostic and therapeutic use, CBN-based phototermal/photodynamic therapeutics, as well as CBN toxicity and biosafety assessment.
We are looking forward to receiving your contributions.
Dr. Danica Jović
Dr. Ivana Borišev
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbon-based nanomaterials
- drug delivery
- fullerenes
- graphene
- carbon nanotubes
- nanodiamonds
- carbon dots
- biocompatibility
- pharmaceutical applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
